AstraZeneca Dividend 2026: Pharmaceutical company, AstraZeneca on Tuesday posted its Q4 FY26 results. The company reported revenue of Rs 579 Cr in Q4 FY26, compared to Rs 480 Cr in Q4 FY25, registering a 20.4 per cent YoY increase. The board also recommended a dividend for its shareholders.
- Revenue: Rs 579 crore in Q4 FY26 vs Rs 480 crore in Q4 FY25, up 20.4 per cent YoY.
Despite the revenue increase, the company’s profit declined.
- Profit: Rs 45 crore in Q4 FY26 vs Rs 58 crore in Q4 FY25, down 23 per cent YoY.
- EBITDA: Rs 61 crore in Q4 FY26 vs Rs 86 crore in Q4 FY25, down 29.4 per cent YoY.
- EBITDA Margin: Contracted sharply by 740 basis points to 10.5 per cent from 17.9 per cent in the year-ago quarter.
Shares of AstraZeneca Pharma India Ltd closed at Rs 8,984 on Tuesday, gaining Rs 188. or 2.14 per cent during the trading session.
The stock had settled at Rs 8,795 in the previous session and opened at Rs 8,777 During the day, it touched an intra-day high of Rs 9,150 and a low of Rs 8,751.
Over the past 52 weeks, the stock has hit a high of Rs 10,653 and a low of Rs 7,630
The stock’s upper price band stands at Rs 10,780, while the lower price band is fixed at Rs 7,187.
(Disclaimer: The above article is meant for informational purposes only and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience consult their financial advisors before making any money-related decisions.)
